Insider Transactions in Q1 2025 at Kal Vista Pharmaceuticals, Inc. (KALV)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 18
2025
|
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
5,104
-1.8%
|
$45,936
$9.82 P/Share
|
|
Feb 18
2025
|
Paul K. Audhya CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,125
-3.02%
|
$28,125
$9.82 P/Share
|
|
Feb 18
2025
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct |
2,601
-2.73%
|
$23,409
$9.82 P/Share
|
|
Feb 17
2025
|
Benjamin L Palleiko CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
9,363
+3.19%
|
-
|
|
Feb 17
2025
|
Paul K. Audhya CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,447
+5.87%
|
-
|
|
Feb 17
2025
|
Christopher Yea CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,204
+4.22%
|
-
|
|
Feb 13
2025
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect |
61,700
+1.16%
|
$555,300
$9.33 P/Share
|
|
Feb 12
2025
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect |
100,000
+1.88%
|
$900,000
$9.23 P/Share
|
|
Feb 11
2025
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect |
26,703
+0.52%
|
$240,327
$9.18 P/Share
|
|
Feb 10
2025
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect |
4,137
+0.08%
|
$37,233
$9.14 P/Share
|
|
Feb 07
2025
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect |
73,649
+1.43%
|
$662,841
$9.29 P/Share
|
|
Feb 03
2025
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect |
14,562
+0.29%
|
$131,058
$9.22 P/Share
|
|
Jan 31
2025
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect |
11,754
+0.23%
|
$94,032
$8.89 P/Share
|
|
Jan 30
2025
|
Venrock Healthcare Capital Partners Iii, L.P. |
BUY
Open market or private purchase
|
Indirect |
43,707
+0.87%
|
$349,656
$8.76 P/Share
|